Antag Therapeutics raised €80M in a Series A round in Dec 2024. The company is based in Copenhagen, Denmark. Investors in the round: Dawn Biopharma, Export and Investment Fund of Denmark (EIFO), Longview Ventures and 4 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €80M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
